To direct the Secretary of Health and Human Services to support research on, and expanded access to, investigational drugs for amyotrophic lateral sclerosis, and for other purposes.
Sponsor and status
Sponsor. Representative for Illinois's 5th congressional district. Democrat.
Last Updated: Dec 21, 2021
Length: 6 pages
What legislators are saying
“Congressman Higgins Announces Approval of the Accelerating Access to Critical Therapies for ALS Act”
— Rep. Brian Higgins [D-NY26] (Co-sponsor) on Dec 10, 2021
What stakeholders are saying
This bill incorporates provisions from:
H.R. 3537 is a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
Bills numbers restart every two years. That means there are other bills with the number H.R. 3537. This is the one from the 117th Congress.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
GovTrack.us. (2022). H.R. 3537 — 117th Congress: Accelerating Access to Critical Therapies for ALS Act. Retrieved from https://www.govtrack.us/congress/bills/117/hr3537
“H.R. 3537 — 117th Congress: Accelerating Access to Critical Therapies for ALS Act.” www.GovTrack.us. 2021. July 1, 2022 <https://www.govtrack.us/congress/bills/117/hr3537>
Accelerating Access to Critical Therapies for ALS Act, Pub. L. No. 117-79, H.R. 3537, 117th Cong. (2021).
|title=H.R. 3537 (117th)
|accessdate=July 1, 2022
|author=117th Congress (2021)
|date=May 25, 2021
|quote=Accelerating Access to Critical Therapies for ALS Act
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.